Pressures such as insufficient government reimbursement and rising Medicare Advantage penetration are contributing to consolidation in home care and hospice, LeadingAge told regulators last week in response to a February request for information surrounding healthcare market competition.
“Sustainable fee-for-service rates that cover the continually rising costs of delivering care are of critical importance,” LeadingAge said. “Outside revenue pressures such as lower reimbursement rates from managed care plans, reduced units of service through accountable and managed care organizations, and an increasing need to be an organization of a certain size in order to contract with managed care organizations and accountable care organizations are also factors that drive consideration of consolidation options.”
One particular concern, LeadingAge noted, is the growing investment in healthcare by private equity firms. Private equity firms have driven a significant share of home care and hospice consolidation in recent years. PE firms had a hand in 35 home health deals, 15 personal care deals and 13 hospice deals last year, according to a recent report. And studies have shown that patients receiving care from PE-owned providers may experience worse health outcomes than patients at nonprofit agencies.
“Recent research suggests that transactions conducted by private equity funds have adversely affected patients, healthcare workers and other stakeholders in some cases including through worse patient outcomes and higher costs for care,” the Department of Justice, Department of Health and Human Services and Federal Trade Commission said in its February request for information.
LeadingAge’s response honed in on private equity firms’ impact on home health and hospice. The organization called for greater oversight of PE investments in healthcare and encouraged government initiatives to promote ownership transparency and program integrity.
“Home healthcare, one of the fastest-growing markets in the healthcare sector, also has attracted significant interest from private equity investors,” LeadingAge wrote. “The private equity business model, which often includes cutting costs to increase cash flow, may exacerbate quality issues that for-profit home health care and hospice companies already face, including insufficient investment in staffing and operations.”
LeadingAge added, “While not all private equity arrangements cause concerns, we agree that these transactions raise policy questions that are important to understand and address.”